ARTICLE | Financial News
Stemline amends IPO
June 25, 2012 7:00 AM UTC
Stemline Therapeutics Inc., New York, N.Y. Business: Cancer Date announced: 6/20/12 Type: IPO To be raised: Up to $50 million Shares: TBD Price: TBD Underwriters: Oppenheimer; RBC Capital Markets; JMP...